The Board of Directors of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has authorized a buyback plan on March 26, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.14 CNY | -0.05% |
|
-1.38% | -11.55% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.55% | 7.39B | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Shanghai Fosun Pharmaceutical Co., Ltd. authorizes a Buyback Plan.